35 studies found for:    "Pars planitis"
Show Display Options
Rank Status Study
21 Enrolling by invitation An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data
Condition: Uveitis
Intervention: Drug: Dose 2 gevokizumab
22 Enrolling by invitation A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
Condition: Uveitis
Intervention: Drug: adalimumab
23 Completed Human Samples and Data Repository
Conditions: Uveitis;   Scleritis
Intervention:
24 Terminated Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
Condition: Non-infectious Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
25 Recruiting Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Condition: Uveitis
Interventions: Drug: Placebo;   Drug: Dose 1 gevokizumab;   Drug: Dose 2 gevokizumab
26 Withdrawn A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
Condition: Uveitis
Intervention: Device: Iontophoresis second generation Eyegate II device
27 Recruiting Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Condition: Uveitis
Interventions: Drug: Placebo;   Drug: Dose 1 gevokizumab;   Drug: Dose 2 gevokizumab
28 Completed The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
Condition: Uveitis
Intervention: Drug: Interferon Gamma 1-b
29 Terminated Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis Study
Condition: Non-infectious Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
30 Withdrawn Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis
Condition: Uveitis
Intervention: Biological: AIN457
31 Recruiting Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Conditions: Uveitis;   Macular Edema;   Uveitis, Posterior;   Uveitis, Anterior;   Panuveitis;   Uveitis, Intermediate
Interventions: Drug: 4 mg CLS-TA;   Drug: 0.8 mg CLS-TA
32 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)
33 Completed Leflunomide to Treat Uveitis
Condition: Uveitis
Intervention: Drug: Leflunomide
34 Completed Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema
Conditions: Uveitis;   Glaucoma
Intervention:
35 Completed
Has Results
Multicenter Uveitis Steroid Treatment (MUST) Trial
Condition: Uveitis
Interventions: Drug: fluocinolone acetonide intraocular implant;   Drug: oral corticosteroid with immunosuppressive agents as needed

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years